share_log
Reuters ·  Mar 3 12:45
C4 Therapeutics Inc : UBS Cuts Target Price to $3.5 From $4
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 267

Recommended

Write a comment